• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Nephrology
  • Neurology
  • Pulmonology

Continuous Glucose Monitoring for Type 2 Diabetes in Primary Care: 2021 Research Review

News
Article

Continuous glucose monitoring for type 2 diabetes patients is gaining exposure in the literature with positive evidence accumulating. Examples follow.

Numerous studies have shown continuous glucose monitoring (CGM) to be beneficial for patients with type 1 diabetes (T1D). Until recently, evidence for the use of CGM for patients with T2D has been lacking.

Studies and reviews published in 2021 are now addressing the use of CGM for patients with T2D, especially those in primary care. Scroll through the slides below for concise summaries of key findings.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
FDA Accepts MannKind sBLA for Inhaled Insulin for Children and Adolescents

FDA Accepts MannKind sBLA for Inhaled Insulin for Children and Adolescents with Diabetes

Grace Halsey
October 13th 2025
Article

The sBLA includes data from the phase 3 INHALE-1 study, which showed Afrezza noninferior to MDI insulin. A PDUFA date is set for May 29, 2026.

Obesity & Type 2 Diabetes: An Expert Discussion

Obesity & Type 2 Diabetes: An Expert Discussion

Sydney Jennings
June 30th 2023
Podcast

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Approximately Half of People with Diabetes Worldwide Unaware They Have the Disease: Daily Dose / Image credit: ©New Africa/AdobeStock

Approximately Half of People with Diabetes Worldwide Unaware They Have the Disease: Daily Dose

Sydney Jennings
September 30th 2025
Article

Your daily dose of the clinical news you may have missed.

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Episode 17: Kidney Outcomes with Tirzepatide in Type 2 Diabetes

Sydney Jennings
July 22nd 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Hiddo Heerspink, PhD, PharmD.

Atopic Dermatitis: The Pipeline and Clinical Approaches That Could Transform the Standard of Care / image credit ©designua/stock.adobe.com

Atopic Dermatitis: The Pipeline and Clinical Approaches That Could Transform the Standard of Care

Patient Care Editorial Staff
September 24th 2025
Article

Patient Care tapped the rich trove of research and expert perspectives from the Revolutionizing Atopic Dermatitis 2025 conference to create a snapshot of the AD care of the future.

Investigational IL-2 Pathway Agonist Rezpegaldesleukin Shows Promise in Phase 2b RESOLVE-AD Trial / image courtesy of George Washington University School of Medicine

Investigational IL-2 Pathway Agonist Rezpegaldesleukin Shows Promise in Phase 2b REZOLVE-AD Trial

Grace Halsey
September 23rd 2025
Article

The findings highlight rezpegaldesleukin's novel broad-based Treg mechanism, suggesting it may be a potent option with potential for disease modification in atopic dermatitis.

© 2025 MJH Life Sciences

All rights reserved.